Secure Login Tips: Abcellera Stock Price

Tuesday, July 5, 2022

Abcellera Stock Price

BMO Capital Markets decreased their target price on shares of AbCellera Biologics from 6100 to 5900 and set an outperform rating on the stock in a research report on Wednesday March 24th. A look at the stock.

Abcellera

Real-time Price Updates for Abcellera Biologics Inc ABCL-Q.

Abcellera stock price. Shares in Abcellera Biologics Inc are currently priced at 2893. The company plans to offer 23 million shares in the IPO. ABCL stock quote history news and other vital information to help you with your stock trading and investing.

Is there a Abcellera Biologics Inc share price forecast 2021. Zacks Investment Research lowered shares of AbCellera Biologics from a hold rating to a sell rating in a research note on Friday April 2nd. ABCL a technology company that has developed a centralized operating system for next-generation antibody discovery and development today announced it has broken ground on an.

The AbCellera IPO filing also provides a price range of 14 to 17 per share for its stock. Stock news by MarketWatch. Abcellera shares were up 265 to 29 in premarket trading Thursday.

ABCL Complete AbCellera Biologics Inc. VANCOUVER British Columbia--BUSINESS WIRE--AbCellera announced the pricing of its initial public offering of 24150000 common shares at a price to the public of 2000 per share. AbCellera Biologics ABCL stock price revenue and financials.

075 265 DATA AS OF Apr 15 2021. Their average twelve-month price target is 5280 predicting that the stock has a possible upside of 6709. There are currently 5 buy ratings for the stock resulting in a consensus rating of Buy.

ABCL AbCellera Stock Price and Discussion Stocktwits. On The Radar Clinical Readouts Chinook Therapeutics Inc. 2215 Yukon Street Vancouver BC V5Y 0A1.

Find the latest AbCellera Biologics Inc. The high price target for ABCL is 5900 and the low price target for ABCL is 4500. ABCL a technology company that has developed a centralized operating system for next-generation antibody discovery and development today announced it has broken ground on an expanded global headquarters in its home city of Vancouver in anticipation of adding hundreds of employees to its current 250-person workforce over the next few years.

View real-time stock prices and stock quotes for a full financial overview. Get the hottest stocks to trade every day before the market opens 100 free. 5 Wall Street analysts have issued ratings and price targets for AbCellera Biologics in the last 12 months.

Spread Lowest Target. Charting Tear Sheets Press Price Performance more. Data is currently not available.

3160 Spread Highest target. 5220 Last Close Price. AbCellera Biologics market cap is 76 b and annual revenue was 1161 m in FY 2019.

AbCellera Biologics Inc. At that level they are trading at 8824 discount to the analyst consensus target price of 000. It will list these shares on the Nasdaq Global.

AbCellera 3003 055 187 AbCellera NASDAQ Updated Apr 28 2021 114 PM. ABCL 3003 055 187 Post-Market 001 003 2745. NASDAQABCL price on Friday Apr 23 rose 034 above its previous days close as an upside momentum from buyers pushed the stocks value to 2933.

ABCL 122 said Monday that terms of its initial public offering have been set which could value the artificial intelligence AI-powered drug discovery company at up. KDNY will present at the the International Society of. AbCellera Biologics Inc.

Spread Average Target.

Abcellera Biologics Inc Stock Info